Hyundai ADM Bio Inc. (KOSDAQ:187660)
15,540
+1,790 (13.02%)
At close: Mar 6, 2026
Hyundai ADM Bio Revenue
In the year 2024, Hyundai ADM Bio had annual revenue of 9.74B KRW, down -29.33%.
Revenue
9.74B
Revenue Growth
-29.33%
P/S Ratio
97.67
Revenue / Employee
60.91M
Employees
160
Market Cap
951.79B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DreamCIS | 62.06B |
| HLB bioStep | 71.47B |
| P&K Skin Research Center | 22.13B |
| C&R Research | 63.97B |
| WOOJUNG BIO | 37.12B |
| DT&CRO CO. | 44.36B |
| SLS BIO | 5.47B |
| BioInfra | 21.92B |